Arijita Deb, PhD

GlaxoSmithKline
Upper Providence, PA, United States

Director, Respiratory Biologics
US Value Evidence and Outcomes (VEO)
GlaxoSmithKline

Disclosure information not submitted.

Presentation(s):

• 0125: Baseline Characteristics in Patients with Eosinophilic Granulomatosis with Polyangiitis in the U.S. Initiating Mepolizumab

  Saturday, November 12, 2022
  1:00 PM – 3:00 PM Eastern Time